Optimizing Biologic Therapy and Clinical Assessment to Improve Outcomes in Rheumatoid Arthritis
On-Demand Slide Lecture with Audio
Sponsored by the University of Kentucky College of Medicine
Produced by North American Center for Continuing Medical Education, LLC.
Statement of Need
Clinical experts in the field of rheumatology support the need to educate and update clinicians with the most up-to-date data on the efficacy of the older and newer biologics in the treatment of rheumatoid arthritis in biologic-naďve patients and in those who failed on a previous biologic. The efficacy of using the same class of biologic versus a biologic with a different mechanism of action in a treatment-failure patient is also addressed.
Presenter
Marc D. Cohen, MD
Professor of Medicine
National Jewish Medical and Research Center
Denver, Colorado
Target Audience
This activity is designed for rheumatologists and other healthcare professionals who manage the treatment of patients with rheumatoid arthritis (RA) and other rheumatic diseases.
Learning Objectives
After completing this activity, participants should be able to:
- Describe the clinical evidence and potential impact of biologic agents in RA
- Apply clinical measurement tools and imaging studies to properly assess disease status in RA
- Institute a plan for early and aggressive management of RA, including methods for switching biologic agents when necessary, to optimize patient outcomes
Activity Overview
This on-demand slide lecture with audio is available with html slides and the presentation transcript.
To be eligible for documentation of credit, participant must participate in the full activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.
There is no fee associated with this activity.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
Release Date: December 5, 2008
Expiration Date: December 5, 2009
Estimated time to complete: 1 hour
For questions regarding this educational activity, please contact Angela Scarnici at 609-630-6208.
Hardware/Software Requirements
All educational activities are accessible via a computer 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.
CME Accreditation
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Kentucky College of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
The University of Kentucky is an Equal Opportunity University.
University of Kentucky College of Medicine test code: MEN09120-02
Independent Clinical Reviewer
Rodolfo V. Curiel, MD, Program Director, Rheumatology fellowship, The George Washington University, Washington, DC
Planning Committee
The planning committee comprises Marc D. Cohen, MD; Mandy Daniel, University of Kentucky College of Medicine; and Randy Robbin, John Savage, Rosemary Hodgson, Richard Tyska, PharmD, and William Kormos, NACCME.
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of the University of Kentucky College of Medicine and NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of the University of Kentucky College of Medicine and NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Cohen: Consultant—Abbott Laboratories, Inc., Amgen Inc., Genentech, Inc., Wyeth Pharmaceuticals; Speaker’s bureau—Abbott Laboratories, Inc., Amgen Inc., Genentech, Inc., Wyeth Pharmaceuticals, ( [Spouse] Speaker’s bureau—Abbott Laboratories, Inc., Amgen Inc., Bristol-Myers Squibb Company, Centocor, Inc., Genentech, Inc. Wyeth Pharmaceuticals)
Dr. Curiel has disclosed no relevant financial relationships
Ms. Daniel, Mr. Robbin, Ms. Hodgson, Mr. Savage, Dr. Tyska, and Mr. Kormos have disclosed no relevant financial relationships with any commercial interests.
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices will be discussed in their presentations.
The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.
Privacy Policy
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2008 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the North American Center for Continuing Medical Education.
Grant Support
Supported by an educational grant from Genentech, Inc and Biogen Idec Inc, Abbott Laboratories, Centocor, Inc, UCB, Inc, Bristol-Myers Squibb Company, and Amgen Inc, and Wyeth Pharmaceuticals.
Representatives of the granting organization(s) may not register on behalf of participants.
